Health Catalyst, Inc. (NASDAQ:HCAT) Receives $4.55 Consensus Target Price from Analysts

Health Catalyst, Inc. (NASDAQ:HCAT) has received a consensus recommendation of “Hold” from the twelve ratings firms that are presently covering the firm, MarketBeat.com reports. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and three have given a buy rating to the company. The average 1 year price target among brokerages that have covered the stock in the last year is $4.5455.

HCAT has been the topic of a number of research analyst reports. Citigroup lowered shares of Health Catalyst from a “buy” rating to a “neutral” rating and decreased their price objective for the stock from $6.50 to $3.50 in a report on Friday, August 8th. Wells Fargo & Company decreased their price objective on shares of Health Catalyst from $10.00 to $6.00 and set an “overweight” rating on the stock in a report on Monday, August 11th. Stifel Nicolaus decreased their price objective on shares of Health Catalyst from $5.50 to $4.50 and set a “hold” rating on the stock in a report on Friday, August 8th. Summit Redstone set a $5.00 price objective on shares of Health Catalyst in a report on Friday, August 29th. Finally, Evercore ISI decreased their price objective on shares of Health Catalyst from $4.00 to $3.00 and set an “in-line” rating on the stock in a report on Wednesday, October 8th.

Health Catalyst Stock Down 0.6%

Shares of NASDAQ:HCAT opened at $3.16 on Thursday. Health Catalyst has a 12 month low of $2.52 and a 12 month high of $9.24. The company’s 50-day moving average price is $3.07 and its two-hundred day moving average price is $3.58. The company has a quick ratio of 1.83, a current ratio of 1.83 and a debt-to-equity ratio of 0.44. The firm has a market cap of $222.37 million, a P/E ratio of -2.09 and a beta of 1.62.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of HCAT. First Light Asset Management LLC boosted its stake in shares of Health Catalyst by 99.1% in the 1st quarter. First Light Asset Management LLC now owns 10,436,807 shares of the company’s stock valued at $47,279,000 after purchasing an additional 5,195,686 shares during the last quarter. Whetstone Capital Advisors LLC bought a new position in shares of Health Catalyst in the 1st quarter valued at about $7,724,000. Nuveen LLC bought a new position in shares of Health Catalyst in the 1st quarter valued at about $2,674,000. Connor Clark & Lunn Investment Management Ltd. boosted its stake in shares of Health Catalyst by 172.6% in the 1st quarter. Connor Clark & Lunn Investment Management Ltd. now owns 694,361 shares of the company’s stock valued at $3,145,000 after purchasing an additional 439,599 shares during the last quarter. Finally, Acadian Asset Management LLC boosted its stake in shares of Health Catalyst by 88.8% in the 1st quarter. Acadian Asset Management LLC now owns 930,229 shares of the company’s stock valued at $4,211,000 after purchasing an additional 437,536 shares during the last quarter. Institutional investors own 85.00% of the company’s stock.

Health Catalyst Company Profile

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.